Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
The art of the possible : the Nottingham art gallery being run by citizens’ assembly
4/11/2025
Football Manager 26 review –a modern sim for the modern game
4/11/2025
Rise of the ‘porno-trolls’ : how one porn platform made millions suing its viewers
4/11/2025
Tell us : are you a UK centenarian or do you know one ?
4/11/2025
Houseplant hacks : can a plastic bag revive a wilting fern ?
4/11/2025
‘I want to ride out on a unicorn every night’ : swords’n’sorcery heavy metal band Castle Rat
4/11/2025